Jul 25, 2016 - Glaxo (GSK) is scheduled to report second-quarter 2016 results on Jul 27.
Jul 25, 2016 - Will Orkambi and Kalydeco help Vertex (VRTX) surpass expectations in Q2?
Jul 25, 2016 - Our proven model shows that Amgen (AMGN) is likely to beat earnings because it has the right combination of two key ingredients.
Jul 22, 2016 - Pharma Industry Outlook: Fundamentals Remain Strong
Jul 21, 2016 - Gilead Sciences (GILD), which is set to report second-quarter 2016 results on Jul 25, delivered a negative earnings surprise of 1.65% last quarter.
Jul 21, 2016 - Sharp growth in Microsoft’s cloud computing business helped both the Dow and the S&P 500 to close at fresh record highs on Wednesday
Jul 21, 2016 - The Zacks Analyst Blog Highlights: Zafgen, Celgene, Amgen, AbbVie and Biogen
Jul 21, 2016 - The combination of Lilly's Zacks Rank #3 and +1.18% ESP makes us very confident in looking for a positive earnings beat on Jul 26.
Jul 20, 2016 - While pipeline & regulatory updates will remain in focus, quite a few major biotech companies will be reporting second quarter results over the next few days including Biogen (BIIB).
Jul 18, 2016 - Valeant Pharmaceuticals International, Inc.'s (VRX) Biologic License Application (BLA) for brodalumab is up for review by an FDA panel.